drugset / Trial / NCT04101682

Continuous Vs Single Shot Block After ACL

NCT04101682

Phase 0 Terminated 9 enrolled Northwell Health
RandomizedParallel-groupOpen-labelHealth-services research

Summary

The investigators will be randomizing patients to either receive an adductor canal block in the operating room postoperatively as single shot of 20-30cc bupivacaine or to have a catheter inserted into the adductor canal which will be attached up to a continuous infusion pump of bupivacaine that will have a set flow rate over the next couple days. The investigators' hypothesis is that patients will have better pain control, sleep, and decreased opioid consumption with the use of a continuous infusion pump

Timeline

Start
2020-09-25
Primary completion
2022-05-17
Completion
2022-05-17

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 20 ml Other
Comparator Bupivacaine Other / unclassified 30 ml Other